Technological Advancements in Wearable Injectors are Resulting in Improved User Experience

The global wearable injectors market is projected to expand at a significant CAGR of 16.4% between 2017 and 2025. Wearable injectors are drug delivery devices that allow the injection of high volumes of biological products/drugs over a long duration, which offers advantages to patients, clinicians, and drug developers. They eliminate risks pertaining to traditional conventional infusion and injection technology. With the means of these devices, patients are able to self-administer at home or work, which also helps in cutting down healthcare expenses.

Technological advancements in wearable injectors are resulting in improved user experience and greater drug administration. Increasing focus of manufacturers to launch advanced products is likely to influence the market positively. For instance, in November 2017, West Pharmaceutical Services launched two new injectors under its SmartDose drug delivery platform. The company’s first-gen SmartDose device is a user-loaded injector, which is designed to deliver large volumes of highly viscous drug products. Its second-gen device is a wearable system that accommodates both Daikyo crystal zenith and glass containers. West’s third-gen device is a pre-loaded version that cuts down the number of steps a patient is required to perform before administration.

Rising prevalence of lifestyle-related diseases such as hypertension and diabetes is augmenting the demand for round-the-clock monitoring of several physiological parameters such as blood sugar levels and blood pressure. This is, thereby, expected to provide a considerable push to the global wearable injectors market. As per the findings of a report by Grand View Research Inc., growing patient inclination toward self-administration can help the market gain tremendous momentum. Mounting cases of needle-stick injuries are also estimated to trigger the growth of the market.

Asia Pacific is anticipated to post the highest CAGR during the forecast period (2017–2025). Favorable government policies are promoting the uptake of wearable devices, which in turn is escalating the growth of the regional market. Some of the key players in the market are Johnson & Johnson Services; Enable Injections; Becton, Dickinson and Company; SteadyMed Therapeutics, Inc.; and F. Hoffmann-La Roche Ltd.

In-Depth Research Report On Wearable Injectors Market:

https://www.grandviewresearch.com/industry-analysis/wearable-injectors-market